← AVANOS MEDICAL, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | $50.5m | ($61.8m) | ($392.1m) | ($72.9m) | |
| Net Income (Loss) Attributable to Parent | $39.8m | $79.3m | $57.5m | ($45.9m) | ($27.2m) | $5.2m | $50.5m | ($61.8m) | ($392.1m) | ($72.9m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | ($32.1m) | ($8.5m) | ($45.9m) | ($27.2m) | — | — | ($9.9m) | ($386.3m) | ($72.9m) | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | $111.4m | $66.0m | $0 | $0 | — | — | ($51.9m) | ($5.8m) | $0 | |
| Depreciation, Depletion and Amortization | $65.2m | $59.5m | $33.5m | $36.9m | $42.9m | $38.3m | $47.7m | $46.1m | $45.5m | $38.9m | |
| Depreciation | $43.0m | $19.0m | $13.5m | $16.9m | $23.5m | $21.6m | $22.0m | $19.2m | $20.3m | $19.7m | |
| Amortization of Intangible Assets | $22.0m | $21.0m | $20.0m | $20.0m | $19.4m | $16.7m | $25.7m | $24.3m | $25.2m | $19.2m | |
| Amortization Cash Flow | — | — | — | — | — | $16.7m | $25.7m | — | — | — | |
| Amortization Of Intangibles | — | — | — | — | — | $16.7m | $25.7m | — | — | — | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $47.7m | $46.1m | $45.5m | $38.9m | |
| Deferred Income Tax Expense (Benefit) | ($26.5m) | ($9.5m) | $3.7m | ($15.0m) | $11.6m | $3.5m | ($3.7m) | ($8.1m) | ($35.9m) | ($7.8m) | |
| Share-based Payment Arrangement, Noncash Expense | $14.8m | $12.6m | $10.5m | $10.5m | $12.1m | $13.2m | $15.9m | $15.8m | $13.8m | $12.6m | |
| Share-based Payment Arrangement, Expense | $15.0m | $13.0m | $10.5m | — | $12.1m | $13.2m | $15.9m | $15.8m | $13.8m | $12.6m | |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | — | — | — | — | — | ($1.1m) | ($1.9m) | — | — | |
| Goodwill and Intangible Asset Impairment | — | — | — | — | — | — | — | — | $436.7m | $77.0m | |
| Goodwill, Impairment Loss | $0 | $0 | — | — | — | — | — | — | — | $77.0m | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | $7.8m | $7.8m | $7.8m | — | — | $0 | |
| Operating Lease, Impairment Loss | — | — | — | — | $9.6m | — | — | — | — | — | |
| Asset Impairment Charge | — | — | — | — | — | — | $0 | $0 | $436.7m | $77.0m | |
| Gain (Loss) on Disposition of Assets | ($3.7m) | ($3.3m) | ($1.5m) | ($600k) | ($2.2m) | ($100k) | — | — | — | — | |
| Gain (Loss) on Disposition of Business | — | — | — | — | — | — | — | ($70.8m) | $0 | $0 | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | — | — | — | — | — | — | ($1.2m) | ($9.3m) | |
| Income Tax Expense (Benefit) | $15.5m | ($40.1m) | ($9.6m) | ($18.1m) | ($33.3m) | $600k | $14.7m | $2.0m | ($17.0m) | $6.7m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $12.2m | $7.8m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | ($8.4m) | $15.3m | ($67.4m) | $800k | ($45.8m) | $10.8m | $24.7m | ($39.0m) | $6.6m | ($30.9m) | |
| Increase (Decrease) in Inventories | ($41.0m) | $16.8m | $34.5m | $21.3m | $21.8m | ($17.2m) | $30.9m | ($4.7m) | ($39.0m) | ($200k) | |
| Proceeds from Stock Options Exercised | — | $4.7m | $17.1m | $5.3m | $3.4m | $6.2m | $1.7m | $1.3m | $1.1m | $700k | |
| Gain (Loss) on Termination of Lease | — | — | — | — | — | — | — | — | $6.9m | — | |
| Goodwill | $1.0b | $764.7m | $783.6m | $800.9m | $802.5m | $801.6m | $819.4m | $796.1m | $455.6m | $394.9m | |
| Inventory Write-down | — | — | — | — | — | — | — | $5.1m | $5.6m | $9.4m | |
| Investment Income, Interest | $600k | $2.5m | $7.8m | $6.7m | $1.2m | $200k | $1.2m | $2.9m | $5.1m | $3.2m | |
| Beginning Cash Position | — | — | — | — | — | — | $118.5m | $127.7m | $87.7m | $107.7m | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $56.7m | ($94.2m) | ($49.1m) | ($37.0m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($135.4m) | $21.6m | ($27.5m) | ($60.6m) | |
| Change In Account Payable | — | — | — | — | — | — | $35.4m | ($14.4m) | ($900k) | $600k | |
| Change In Accrued Expense | — | — | — | — | — | — | ($7.1m) | ($27.7m) | ($11.4m) | ($12.9m) | |
| Change In Inventory | — | — | — | — | — | — | ($30.9m) | $4.7m | $39.0m | $200k | |
| Change In Payable | — | — | — | — | — | — | $35.4m | ($14.4m) | ($900k) | $600k | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | $28.3m | ($42.1m) | ($12.3m) | ($12.3m) | |
| Change In Prepaid Assets | — | — | — | — | — | — | $3.0m | ($19.6m) | $14.9m | $1.4m | |
| Change In Receivables | — | — | — | — | — | — | ($24.7m) | $39.0m | ($6.6m) | $30.9m | |
| Change In Working Capital | — | — | — | — | — | — | ($24.3m) | ($18.0m) | $35.0m | $20.2m | |
| Changes In Account Receivables | — | — | — | — | — | — | ($24.7m) | $39.0m | ($6.6m) | $30.9m | |
| Changes In Cash | — | — | — | — | — | — | $12.2m | ($40.2m) | $24.1m | ($22.9m) | |
| End Cash Position | — | — | — | — | — | — | $127.7m | $87.7m | $107.7m | $89.8m | |
| Financing Cash Flow | — | — | — | — | — | — | $56.7m | ($94.2m) | ($49.1m) | ($37.0m) | |
| Free Cash Flow | — | — | — | — | — | — | $71.6m | $14.6m | $82.9m | $43.1m | |
| Gain Loss On Sale Of Business | — | — | — | — | — | — | $0 | $70.8m | $0 | $0 | |
| Investing Cash Flow | — | — | — | — | — | — | ($135.4m) | $21.6m | ($27.5m) | ($60.6m) | |
| Net Business Purchase And Sale | — | — | — | — | — | — | ($116.1m) | $39.4m | ($9.7m) | ($33.0m) | |
| Operating Gains Losses | — | — | — | — | — | — | $1.1m | $72.7m | $1.2m | $9.3m | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | $1.7m | $1.3m | $1.1m | $700k | |
| Purchase Of Business | — | — | — | — | — | — | ($116.1m) | ($49.6m) | ($11.8m) | ($33.0m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($45.5m) | ($19.1m) | ($12.8m) | ($3.3m) | |
| Sale Of Business | — | — | — | — | — | — | $0 | $89.0m | $2.1m | $0 | |
| Stock Based Compensation | — | — | — | — | — | — | $15.9m | $15.8m | $13.8m | $12.6m | |
| Other Operating Income (Expense), Net | ($18.3m) | ($20.1m) | ($8.2m) | ($21.1m) | ($51.9m) | ($22.8m) | ($3.5m) | ($13.3m) | $3.9m | $400k | |
| Net Cash Provided by (Used in) Operating Activities | $188.8m | $144.2m | ($145.6m) | ($74.5m) | ($2.5m) | $87.3m | $90.9m | $32.4m | $100.7m | $74.7m | |
| Cash flows from investing activities: | |||||||||||
| Capital Expenditure | — | — | — | — | — | — | ($19.3m) | ($17.8m) | ($17.8m) | ($31.6m) | |
| Capital Expenditure Reported | $29.1m | $43.2m | $49.1m | $50.6m | $20.2m | $21.0m | ($19.3m) | ($17.8m) | ($17.8m) | ($31.6m) | |
| Payments to Acquire Businesses, Net of Cash Acquired | $175.0m | $0 | $65.7m | $57.5m | $0 | $0 | $116.1m | $49.6m | $0 | $28.0m | |
| Payments to Acquire Investments | — | — | — | — | $4.0m | $0 | $0 | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($200.9m) | ($43.1m) | $639.5m | ($108.1m) | ($24.2m) | ($21.0m) | ($135.4m) | $21.6m | ($27.5m) | ($60.6m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | $0 | — | — | — | — | — | — | — | — | — | |
| Issuance Of Debt | — | — | — | — | — | — | $400.0m | $55.0m | $20.0m | $0 | |
| Long Term Debt Issuance | — | — | — | — | — | — | $400.0m | $55.0m | $20.0m | $0 | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $103.4m | ($64.7m) | ($33.6m) | ($34.4m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $103.4m | ($64.7m) | ($33.6m) | ($34.4m) | |
| Repayments of Long-term Debt | $0 | $0 | — | — | — | — | — | — | — | — | |
| Long Term Debt Payments | — | — | — | — | — | — | ($296.6m) | ($119.7m) | ($53.6m) | ($34.4m) | |
| Repayment Of Debt | — | — | — | — | — | — | ($296.6m) | ($119.7m) | ($53.6m) | ($34.4m) | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($45.5m) | ($19.1m) | ($12.8m) | ($3.3m) | |
| Payments for Repurchase of Common Stock | $900k | $2.5m | $900k | $3.6m | $900k | $11.5m | $45.5m | $19.1m | $12.8m | $3.3m | |
| Common Stock Payments | — | — | — | — | — | — | ($45.5m) | ($19.1m) | ($12.8m) | ($3.3m) | |
| Dividends paid | — | — | $0 | — | — | — | — | — | — | — | |
| Proceeds from (Payments for) Other Financing Activities | $0 | — | — | — | — | — | — | — | — | — | |
| Net Other Financing Charges | — | — | — | — | — | — | ($2.9m) | ($11.7m) | ($3.8m) | — | |
| Net Cash Provided by (Used in) Financing Activities | ($1.4m) | $2.2m | ($324.4m) | $1.5m | ($70.0m) | ($55.3m) | $56.7m | ($94.2m) | ($49.1m) | ($37.0m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($2.3m) | $2.7m | ($4.7m) | $1.9m | $2.9m | ($4.0m) | ($3.0m) | $200k | ($4.1m) | $5.0m | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | ($3.0m) | $200k | ($4.1m) | $5.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($2.3m) | $2.7m | $164.8m | ($179.2m) | ($93.8m) | $7.0m | $9.2m | ($40.0m) | $20.0m | ($17.9m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $384.5m | $205.3m | $111.5m | $118.5m | $127.7m | $87.7m | $107.7m | $89.8m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $9.2m | ($40.0m) | $20.0m | ($17.9m) | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $29.9m | $28.7m | $20.6m | $16.7m | $16.8m | $3.0m | $8.1m | $14.7m | $11.5m | $6.5m | |
| Income Taxes Paid, Net | $29.1m | $21.4m | $96.6m | $8.4m | $0 | ($45.0m) | ($2.9m) | $23.6m | $3.3m | $14.1m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.